Dianthus Therapeutics, Inc. (DNTH)

45.52 +0.66 (+1.47%) USD  |  NASDAQ  |  Jan 14, 15:10
More

Dianthus Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for DNTH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Cytokinetics, Inc. Upgrade
Lexicon Pharmaceuticals, Inc. Upgrade
Day One Biopharmaceuticals, Inc. Upgrade
CEL-SCI Corp. Upgrade
AIM ImmunoTech, Inc. Upgrade